Results 91 to 100 of about 3,493 (205)

LAIV effect on markers of systemic NK cells (regardless of treatment).

, 2016
LAIV effect on markers of systemic NK cells (regardless of treatment).
Ilona Jaspers (327122), Terry L. Noah (575076), Haibo Zhou (575077), Carole Robinette (575084), Megan Meyer (327120), Hongtao Zhang (167639), Rebecca N. Bauer (575080), Shannon Jones (575082), Loretta Müller (575079)   +8 more
core   +1 more source

Associated virus-bacterial vaccine based on seasonal LAIV and S. pneumoniae chimeric peptide provide protection against post-influenza pneumococcal infection in mouse model (Figures.pptx)

, 2021
Severe influenza complications are often caused by Streptococcus pneumoniae infection, which presents the most common cause of community-acquired pneumonia.
Yulia Desheva (5134388), Tatiana Kramskaya (11674805), Andrey Rekstin (11674812), Nadezhda Petkova (11674811), Igor Losev (11674807), Galina Leontieva (11674802), Alexander Suvorov (11674815)   +6 more
core   +1 more source

Laiv' on poika syntynyt ja laiv' on poika tuotu (3/8, 5/8 a)

Laulun sanat: Laiv' on poika syntynyt ja laiv' on poika tuotu; laivan kannen katon pääll' on ristimäviinat ...

core   +1 more source

Real-world comparison of live attenuated and inactivated influenza vaccine effectiveness in Italian children

Vaccine: X
Background: Live attenuated (LAIV) and inactivated (IIV) influenza vaccines provide comparable protection in children, but differences in the timing of protection during the influenza season remain poorly characterized in real-world settings.
Vera Rigamonti, Anna Cantarutti, Vittorio Torri, Francesca Ieva, Carlo Giaquinto, Costanza Di Chiara, Daniele Donà, Anna Cantarutti, Riccardo Boracchini, Vera Rigamonti, Costanza Di Chiara, Daniele Donà, Giulia Brigadoi, Susanna Maria Roberta Esposito, Beatrice Rita Campana, Hajrie Seferi, Valentina Fainardi, Alberto Argentiero, Alberto Villani, Anna Chiara Vittucci, Livia Antilici De Martini Di Valle Aperta   +20 more
doaj   +1 more source

Preparation and evaluation of a novel, live, attenuated influenza H1N1 vaccine strain produced by a modified classical reassortment method

Human Vaccines & Immunotherapeutics, 2018
Live attenuated influenza vaccine (LAIV)-based Vero cells could provide a better choice to control and prevent influenza virus infections. This study used the human influenza virus A/Yunnan/1/2005Vca(H3N2) (YN/05Vca) as a donor strain.
Yunfeng Long, Lei Ma, Ze Liu, Shaohui Song, Xingliang Geng, Fan Yang, Qi Guo, Zhuofan Li, Weidong Li, Guoyang Liao   +9 more
doaj   +1 more source

Immunogenicity and Protective Efficacy of Seasonal Human Live Attenuated Cold-Adapted Influenza Virus Vaccine in Pigs

Frontiers in Immunology, 2019
Influenza A virus infection is a global health threat to livestock and humans, causing substantial mortality and morbidity. As both pigs and humans are readily infected with influenza viruses of similar subtype, the pig is a robust and appropriate model ...
Barbara Holzer, Sophie B. Morgan, Veronica Martini, Rajni Sharma, Becky Clark, Christopher Chiu, Francisco J. Salguero, Elma Tchilian   +7 more
doaj   +1 more source

Could trivalent LAIV protect against both genetic lineages of influenza B virus?

Vaccine Research, 2019
Introduction: The global co-circulation of two influenza B virus genetic lineages known as B/Yamagata and B/Victoria may lead to a mismatch between the circulating virus and the strain recommended for use in influenza vaccines. Little is known about the protective efficacy of unmatched influenza B strains, especially when it comes to live attenuated ...
Irina Kiseleva, Ekaterina Stepanova, Elena Krutikova, Svetlana Donina, Andrey Rekstin, Ekaterina Bazhenova, Maria Pisareva, Anastasia Katelnikova, Kirill Kryshen, Arman Muzhikyan, Elena Grigorieva, Larisa Rudenko   +11 more
openaire   +2 more sources

Live Attenuated Influenza Vaccines engineered to express the nucleoprotein of a recent isolate stimulate human influenza CD8+ T cells more relevant to current infections

Human Vaccines & Immunotherapeutics, 2018
Live attenuated influenza vaccines (LAIV) induce CD8+ T lymphocyte responses that play an important role in killing virus-infected cells. Despite the relative conservation of internal influenza A proteins, the epitopes recognized by T cells can undergo ...
D. Korenkov, T. H. O. Nguyen, I. Isakova-Sivak, T. Smolonogina, L. E. Brown, K. Kedzierska, L. Rudenko   +6 more
doaj   +1 more source

Planeamiento estratégico para Laive

, 2019
In this document it is presented the roll out of the strategic plan corresponding to the period 2018-2030 for Laive Company, which is mainly focused in the production and selling in the Peruvian market of dairy products and its derivatives, being the third largest company in the industry with a participation of 9% sales.
Amaya Ramírez, Daniel, González Cruz, Yvette, Granada Gutiérrez, Didier, Valdiviezo Jerónimo, Víctor Igor Seligman   +3 more
openaire   +2 more sources

Comparison of yearly report distributions of GBS and GBS-related adverse events associated with TIV and LAIV.

, 2012
LAIV was recently released and therefore data available are from 2003 onward. The raw number of occurrences was scaled to percentages by the number of reports in each year.
Brian D. Athey (116831), Howard Markel (116826), Kerby A. Shedden (116824), Sirarat Sarntivijai (116820), Gilbert S. Omenn (116828), Yongqun He (20286), Zuoshuang Xiang (20284)   +6 more
core   +1 more source